These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 26073897)

  • 1. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.
    Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
    J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.
    Domanska UM; Timmer-Bosscha H; Nagengast WB; Oude Munnink TH; Kruizinga RC; Ananias HJ; Kliphuis NM; Huls G; De Vries EG; de Jong IJ; Walenkamp AM
    Neoplasia; 2012 Aug; 14(8):709-18. PubMed ID: 22952424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
    Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR
    Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Zhu WB; Zhao ZF; Zhou X
    J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
    Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
    Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
    Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
    Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.
    Burger JA; Stewart DJ; Wald O; Peled A
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):621-30. PubMed ID: 21504328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.
    Wuchter P; Leinweber C; Saffrich R; Hanke M; Eckstein V; Ho AD; Grunze M; Rosenhahn A
    Cell Tissue Res; 2014 Feb; 355(2):315-26. PubMed ID: 24337688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
    Hirbe AC; Morgan EA; Weilbaecher KN
    Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
    Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
    World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.
    Berning P; Schaefer C; Clemens D; Korsching E; Dirksen U; Potratz J
    Cell Commun Signal; 2018 May; 16(1):21. PubMed ID: 29776413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    Yang B; Pan CS; Li Q; Yang Z; Long FX; Fan JY; Wang CS; Han JY; Tang DX
    PLoS One; 2019; 14(2):e0201504. PubMed ID: 30789971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor.
    Lin G; Yang R; Banie L; Wang G; Ning H; Li LC; Lue TF; Lin CS
    Prostate; 2010 Jul; 70(10):1066-73. PubMed ID: 20232361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
    Taichman RS; Cooper C; Keller ET; Pienta KJ; Taichman NS; McCauley LK
    Cancer Res; 2002 Mar; 62(6):1832-7. PubMed ID: 11912162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
    Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
    Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.